Literature DB >> 25659773

Prospective controlled study of the safety and oncological outcomes of ELAPE procure with definitive anatomic landmarks versus conventional APE for lower rectal cancer.

Z Shen1, Y Ye2, X Zhang1, Q Xie1, M Yin1, X Yang1, K Jiang1, B Liang1, S Wang3.   

Abstract

BACKGROUND: The use of extra-levator abdominoperineal resection (ELAPE) procedure for lower rectal cancer is controversial. It is unclear whether the ELAPE procedure could improve surgical safety and lead to better oncological outcomes.
METHODS: Sixty-nine lower rectal cancer patients who underwent ELAPE (36 cases) or conventional abdominoperineal resection (APE; 33 cases) between June 2011 and February 2013 were prospectively investigated. Clinicopathological variables including blood loss, intraoperative perforation (IOP) rate, circumferential resection margin (CRM) involvement, lymph node harvest, the postoperative complications, urinary and sexual function, quality of life (QOL), local recurrence rate and survival were recorded and compared.
RESULTS: Blood loss (P = 0.021), perineal wound complication (P = 0.039), IOP rate (P = 0.028), local recurrence (P = 0.034) were significantly less frequent in the ELAPE group. There was greater CRM involvement in the conventional APE group but no statistical difference between the two groups. Urinary function, sexual function and QOL were not significantly different between the two groups. Overall survival and progression-free survival were not significantly different between two groups, even when survival was analyzed according to TNM stage, T stage, N stage, and with or without neoadjuvant chemoradiotherapy. In patients who underwent ELAPE there was no statistical difference in postoperative complications between younger and elderly patients (age ≥60).
CONCLUSIONS: ELAPE procedure with definitive anatomic landmarks demonstrated surgical safety and decreased local recurrence for lower rectal cancer patients including the elderly, but there were no survival improvements in compared to conventional APE procedure.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  ELAPE; Extralevator abdominoperineal excision; Rectal cancer

Mesh:

Year:  2015        PMID: 25659773     DOI: 10.1016/j.ejso.2015.01.017

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Long-term outcome of extralevator abdominoperineal excision (ELAPE) for low rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Anja Sims; Thomas Kittner; Eric Puffer; Joerg Zimmer; Dorothea Bleyl; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2016-09-09       Impact factor: 2.571

2.  Trans-perineal minimally invasive surgery during laparoscopic abdominoperineal resection for low rectal cancer.

Authors:  Daiki Yasukawa; Tomohide Hori; Yoshio Kadokawa; Shigeru Kato; Yuki Aisu; Suguru Hasegawa
Journal:  Surg Endosc       Date:  2018-07-09       Impact factor: 4.584

3.  Extralevator versus standard abdominoperineal excision in locally advanced rectal cancer: a retrospective study with long-term follow-up.

Authors:  Anu Carpelan; J Karvonen; P Varpe; A Rantala; A Kaljonen; J Grönroos; H Huhtinen
Journal:  Int J Colorectal Dis       Date:  2018-02-14       Impact factor: 2.571

4.  Tailored concept for the plastic closure of pelvic defects resulting from extralevator abdominoperineal excision (ELAPE) or pelvic exenteration.

Authors:  Julia Jackisch; Thomas Jackisch; Joerg Roessler; Anja Sims; Holger Nitzsche; Pia Mann; Sören Torge Mees; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2022-06-25       Impact factor: 2.796

5.  Similar long-term overall and disease-free survival after conventional and extralevator abdominoperineal excision-a nationwide study.

Authors:  Mads Klein; Emilie Colov; Ismail Gögenur
Journal:  Int J Colorectal Dis       Date:  2016-04-29       Impact factor: 2.571

6.  Extralevator abdominoperineal excision for rectal cancer with biological mesh for pelvic floor reconstruction.

Authors:  Wei Ge; Song-Song Jiang; Wang Qi; Hao Chen; Li-Ming Zheng; Gang Chen
Journal:  Oncotarget       Date:  2017-01-31

Review 7.  Extralevator abdominoperineal excision for advanced low rectal cancer: Where to go.

Authors:  Yu Tao; Jia-Gang Han; Zhen-Jun Wang
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

8.  Oncological outcomes of abdominoperineal resection for the treatment of low rectal cancer: A retrospective review of a single UK tertiary centre experience.

Authors:  Anwar Hussain; Fahad Mahmood; Andrew D W Torrance; Helen Clarke; Cordelia Howitt; Robin Dawson
Journal:  Ann Med Surg (Lond)       Date:  2018-06-26

9.  Standard versus extralevator abdominoperineal excision and oncologic outcomes for patients with distal rectal cancer: A meta-analysis.

Authors:  Yunfeng Zhang; Duo Wang; Lizhe Zhu; Bin Wang; Xiaoxia Ma; Bohui Shi; Yu Yan; Can Zhou
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

10.  Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer: a meta-analysis.

Authors:  Xin-Yu Qi; Ming Cui; Mao-Xing Liu; Kai Xu; Fei Tan; Zhen-Dan Yao; Nan Zhang; Hong Yang; Cheng-Hai Zhang; Jia-Di Xing; Xiang-Qian Su
Journal:  Chin Med J (Engl)       Date:  2019-10-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.